ARTICLE | Clinical News
Patanase olopatadine hydrochloride regulatory update
August 3, 2009 7:00 AM UTC
Alcon disclosed that last quarter it submitted an sNDA to FDA for Patanase olopatadine hydrochloride nasal spray to treat seasonal allergic rhinitis in pediatric patients ages 6 months to 12 years. Th...